FTSE recovery grinds to a halt
Drugs giant GlaxoSmithKline gave investors a headache today as the London market’s recent resurgence ground to a halt.
The FTSE 100 Index shed 112 points to end the day hanging on above the 4,000 barrier at 4006.9 as heavyweight stocks slipped back.